| 0 |
ACQUIRED FACTOR V DEFICIENCY |
21 |
0.1909 |
| 1 |
COAGULATION FACTOR DEFICIENCY |
30 |
0.1863 |
| 2 |
COAGULATION FACTOR V LEVEL ABNORMAL |
21 |
0.1707 |
| 3 |
BRAIN NATRIURETIC PEPTIDE DECREASED |
4 |
0.0476 |
| 4 |
FACTOR V LEIDEN MUTATION |
17 |
0.0428 |
| 5 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
32 |
0.0345 |
| 6 |
BRONCHOMALACIA |
3 |
0.0227 |
| 7 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
15 |
0.0168 |
| 8 |
JEJUNOSTOMY |
3 |
0.0165 |
| 9 |
CREATININE RENAL CLEARANCE INCREASED |
10 |
0.0134 |
| 10 |
MULTIPLE DRUG THERAPY |
9 |
0.0119 |
| 11 |
TOXIC OPTIC NEUROPATHY |
5 |
0.0115 |
| 12 |
SEDATION COMPLICATION |
29 |
0.0114 |
| 13 |
TRACHEITIS |
8 |
0.0105 |
| 14 |
BRONCHOSPASM PARADOXICAL |
3 |
0.0100 |
| 15 |
DEATH OF RELATIVE |
4 |
0.0099 |
| 16 |
INFECTIVE EXACERBATION OF BRONCHIECTASIS |
3 |
0.0098 |
| 17 |
ASPERGILLUS TEST POSITIVE |
3 |
0.0097 |
| 18 |
DEFECT CONDUCTION INTRAVENTRICULAR |
3 |
0.0093 |
| 19 |
GIARDIASIS |
3 |
0.0088 |
| 20 |
TRACHEAL HAEMORRHAGE |
3 |
0.0085 |
| 21 |
INCREASED VISCOSITY OF BRONCHIAL SECRETION |
5 |
0.0078 |
| 22 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
3 |
0.0077 |
| 23 |
TRACHEOMALACIA |
3 |
0.0076 |
| 24 |
CREATININE RENAL CLEARANCE DECREASED |
29 |
0.0072 |
| 25 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
37 |
0.0068 |
| 26 |
STATUS ASTHMATICUS |
3 |
0.0064 |
| 27 |
CYSTIC FIBROSIS |
35 |
0.0063 |
| 28 |
MULTIPLE ALLERGIES |
48 |
0.0061 |
| 29 |
INFUSION SITE BRUISING |
13 |
0.0060 |
| 30 |
INFUSION SITE URTICARIA |
4 |
0.0060 |
| 31 |
INFUSION SITE DISCOLOURATION |
5 |
0.0057 |
| 32 |
ESSENTIAL HYPERTENSION |
10 |
0.0055 |
| 33 |
OEDEMATOUS PANCREATITIS |
3 |
0.0053 |
| 34 |
URINARY TRACT INFECTION PSEUDOMONAL |
3 |
0.0050 |
| 35 |
CHRONIC RESPIRATORY FAILURE |
6 |
0.0050 |
| 36 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
4 |
0.0047 |
| 37 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
5 |
0.0047 |
| 38 |
ENTEROVIRUS INFECTION |
4 |
0.0046 |
| 39 |
CYSTOCELE |
4 |
0.0046 |
| 40 |
HYPERMAGNESAEMIA |
3 |
0.0046 |
| 41 |
KIDNEY ENLARGEMENT |
5 |
0.0046 |
| 42 |
INFUSION SITE HAEMORRHAGE |
15 |
0.0046 |
| 43 |
SPUTUM ABNORMAL |
3 |
0.0045 |
| 44 |
INFUSION SITE RASH |
6 |
0.0044 |
| 45 |
RHINOVIRUS INFECTION |
17 |
0.0044 |
| 46 |
TRACHEOSTOMY |
6 |
0.0042 |
| 47 |
VENTRICULAR HYPOKINESIA |
13 |
0.0040 |
| 48 |
SPUTUM RETENTION |
4 |
0.0040 |
| 49 |
INFUSION SITE DISCHARGE |
7 |
0.0040 |
| 50 |
INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION |
3 |
0.0039 |
| 51 |
DIAPHRAGMATIC DISORDER |
3 |
0.0039 |
| 52 |
PNEUMONIA PSEUDOMONAL |
6 |
0.0039 |
| 53 |
CROUP INFECTIOUS |
3 |
0.0038 |
| 54 |
INFUSION SITE PRURITUS |
12 |
0.0038 |
| 55 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
5 |
0.0037 |
| 56 |
RENAL FUNCTION TEST ABNORMAL |
17 |
0.0037 |
| 57 |
DYSCHROMATOPSIA |
3 |
0.0036 |
| 58 |
IMPAIRED QUALITY OF LIFE |
52 |
0.0036 |
| 59 |
MAST CELL ACTIVATION SYNDROME |
5 |
0.0036 |
| 60 |
VOCAL CORD DISORDER |
7 |
0.0035 |
| 61 |
NOROVIRUS INFECTION |
5 |
0.0035 |
| 62 |
PULMONARY CAVITATION |
3 |
0.0034 |
| 63 |
RESPIRATORY TRACT INFECTION VIRAL |
8 |
0.0034 |
| 64 |
ANAEMIA OF CHRONIC DISEASE |
3 |
0.0033 |
| 65 |
BRONCHITIS CHRONIC |
8 |
0.0033 |
| 66 |
PSEUDOMONAS INFECTION |
27 |
0.0031 |
| 67 |
PROSTATE INFECTION |
3 |
0.0031 |
| 68 |
PNEUMONIA STAPHYLOCOCCAL |
6 |
0.0030 |
| 69 |
INFUSION SITE SWELLING |
19 |
0.0030 |
| 70 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
8 |
0.0030 |
| 71 |
BRONCHIECTASIS |
20 |
0.0030 |
| 72 |
SEASONAL ALLERGY |
42 |
0.0030 |
| 73 |
NASAL INFLAMMATION |
3 |
0.0028 |
| 74 |
NEPHROGENIC ANAEMIA |
13 |
0.0028 |
| 75 |
INFUSION SITE MASS |
3 |
0.0028 |
| 76 |
CONJUNCTIVITIS ALLERGIC |
4 |
0.0027 |
| 77 |
BLOOD CALCIUM DECREASED |
30 |
0.0027 |
| 78 |
PNEUMONIA INFLUENZAL |
3 |
0.0025 |
| 79 |
PULMONARY FUNCTION TEST DECREASED |
11 |
0.0025 |
| 80 |
INFUSION SITE WARMTH |
3 |
0.0024 |
| 81 |
POST-ACUTE COVID-19 SYNDROME |
3 |
0.0024 |
| 82 |
PULMONARY PAIN |
7 |
0.0024 |
| 83 |
HYPERPARATHYROIDISM SECONDARY |
6 |
0.0024 |
| 84 |
VEIN RUPTURE |
4 |
0.0024 |
| 85 |
PARANASAL SINUS DISCOMFORT |
9 |
0.0024 |
| 86 |
BRONCHIAL SECRETION RETENTION |
3 |
0.0024 |
| 87 |
INFUSION SITE IRRITATION |
3 |
0.0023 |
| 88 |
CATHETER SITE ERYTHEMA |
5 |
0.0023 |
| 89 |
ASTHMA |
264 |
0.0023 |
| 90 |
HYPERPHOSPHATAEMIA |
5 |
0.0023 |
| 91 |
CONGENITAL ANOMALY |
18 |
0.0023 |
| 92 |
CENTRAL VENOUS CATHETERISATION |
7 |
0.0023 |
| 93 |
ACUTE SINUSITIS |
4 |
0.0023 |
| 94 |
SPUTUM INCREASED |
5 |
0.0023 |
| 95 |
PNEUMONIA FUNGAL |
9 |
0.0023 |
| 96 |
CARBON DIOXIDE INCREASED |
3 |
0.0022 |
| 97 |
PNEUMONIA VIRAL |
7 |
0.0022 |
| 98 |
TORSADE DE POINTES |
17 |
0.0022 |
| 99 |
DISCHARGE |
3 |
0.0022 |
| 100 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
111 |
0.0021 |
| 101 |
INCORRECT DRUG ADMINISTRATION RATE |
9 |
0.0021 |
| 102 |
LEFT VENTRICULAR DYSFUNCTION |
14 |
0.0021 |
| 103 |
ADENOVIRUS INFECTION |
6 |
0.0021 |
| 104 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
3 |
0.0021 |
| 105 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
4 |
0.0020 |
| 106 |
PRECANCEROUS SKIN LESION |
3 |
0.0020 |
| 107 |
RHINITIS ALLERGIC |
9 |
0.0020 |
| 108 |
ORTHOSTATIC HYPOTENSION |
35 |
0.0020 |
| 109 |
PARAINFLUENZAE VIRUS INFECTION |
3 |
0.0020 |
| 110 |
RUBBER SENSITIVITY |
3 |
0.0020 |
| 111 |
INJECTION SITE PARAESTHESIA |
3 |
0.0020 |
| 112 |
NEURITIS |
3 |
0.0019 |
| 113 |
INFUSION SITE PAIN |
25 |
0.0019 |
| 114 |
GASTROSTOMY |
3 |
0.0019 |
| 115 |
CATHETER SITE PAIN |
5 |
0.0019 |
| 116 |
GASTROINTESTINAL STOMA COMPLICATION |
3 |
0.0019 |
| 117 |
PHARYNGEAL PARAESTHESIA |
3 |
0.0019 |
| 118 |
AORTIC VALVE DISEASE |
3 |
0.0019 |
| 119 |
PULMONARY ARTERIAL PRESSURE INCREASED |
3 |
0.0018 |
| 120 |
PARANASAL SINUS HYPERSECRETION |
7 |
0.0018 |
| 121 |
BREATH SOUNDS ABNORMAL |
9 |
0.0018 |
| 122 |
RESPIRATORY TRACT INFECTION |
47 |
0.0018 |
| 123 |
CATHETERISATION CARDIAC |
8 |
0.0018 |
| 124 |
ANXIETY DISORDER |
6 |
0.0018 |
| 125 |
INFUSION SITE ERYTHEMA |
15 |
0.0018 |
| 126 |
ACUTE RESPIRATORY FAILURE |
34 |
0.0018 |
| 127 |
OXYGEN SATURATION ABNORMAL |
5 |
0.0018 |
| 128 |
PERIARTHRITIS |
4 |
0.0018 |
| 129 |
VITAMIN D DEFICIENCY |
17 |
0.0017 |
| 130 |
MYCOBACTERIAL INFECTION |
3 |
0.0017 |
| 131 |
SPLENIC INFARCTION |
3 |
0.0017 |
| 132 |
MITRAL VALVE DISEASE |
3 |
0.0017 |
| 133 |
RADIUS FRACTURE |
4 |
0.0017 |
| 134 |
BLOOD IMMUNOGLOBULIN E INCREASED |
4 |
0.0017 |
| 135 |
OTOTOXICITY |
3 |
0.0016 |
| 136 |
EYELIDS PRURITUS |
5 |
0.0016 |
| 137 |
SPUTUM DISCOLOURED |
15 |
0.0016 |
| 138 |
SECRETION DISCHARGE |
19 |
0.0015 |
| 139 |
PRODUCTIVE COUGH |
72 |
0.0015 |
| 140 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
13 |
0.0015 |
| 141 |
CHEST INJURY |
3 |
0.0014 |
| 142 |
LUNG CONSOLIDATION |
4 |
0.0014 |
| 143 |
PNEUMONIA BACTERIAL |
13 |
0.0014 |
| 144 |
LUNG TRANSPLANT |
5 |
0.0014 |
| 145 |
FORCED EXPIRATORY VOLUME DECREASED |
4 |
0.0014 |
| 146 |
RESPIRATORY SYMPTOM |
4 |
0.0014 |
| 147 |
JAW FRACTURE |
3 |
0.0014 |
| 148 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
4 |
0.0014 |
| 149 |
CANDIDA INFECTION |
23 |
0.0014 |
| 150 |
VENTRICULAR EXTRASYSTOLES |
14 |
0.0013 |
| 151 |
INFUSION SITE REACTION |
4 |
0.0013 |
| 152 |
CHRONIC SINUSITIS |
5 |
0.0013 |
| 153 |
HYPERCAPNIA |
4 |
0.0013 |
| 154 |
BLOOD LOSS ANAEMIA |
3 |
0.0013 |
| 155 |
RESPIRATORY TRACT CONGESTION |
21 |
0.0013 |
| 156 |
OXYGEN SATURATION DECREASED |
74 |
0.0013 |
| 157 |
EYE INJURY |
4 |
0.0013 |
| 158 |
INFUSION SITE INFECTION |
3 |
0.0013 |
| 159 |
FLANK PAIN |
12 |
0.0013 |
| 160 |
MYOPIA |
3 |
0.0013 |
| 161 |
SEDATION |
33 |
0.0013 |
| 162 |
SINUS CONGESTION |
17 |
0.0013 |
| 163 |
ORTHOPNOEA |
4 |
0.0013 |
| 164 |
OXYGEN CONSUMPTION INCREASED |
3 |
0.0013 |
| 165 |
OBSTRUCTION |
5 |
0.0013 |
| 166 |
ATELECTASIS |
12 |
0.0012 |
| 167 |
UPPER RESPIRATORY TRACT INFECTION |
56 |
0.0012 |
| 168 |
OTITIS MEDIA |
4 |
0.0012 |
| 169 |
DEVICE INFUSION ISSUE |
3 |
0.0012 |
| 170 |
SUFFOCATION FEELING |
3 |
0.0012 |
| 171 |
EAR INFECTION |
32 |
0.0012 |
| 172 |
BRONCHITIS |
89 |
0.0012 |
| 173 |
GASTROINTESTINAL TUBE INSERTION |
3 |
0.0012 |
| 174 |
INCREASED BRONCHIAL SECRETION |
3 |
0.0012 |
| 175 |
HEPATOSPLENOMEGALY |
3 |
0.0012 |
| 176 |
BRONCHOPNEUMONIA |
4 |
0.0012 |
| 177 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
3 |
0.0011 |
| 178 |
ORAL CANDIDIASIS |
15 |
0.0011 |
| 179 |
BRONCHIOLITIS |
4 |
0.0011 |
| 180 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
54 |
0.0011 |
| 181 |
SINUSITIS |
115 |
0.0011 |
| 182 |
STEATORRHOEA |
3 |
0.0011 |
| 183 |
FOOD POISONING |
6 |
0.0011 |
| 184 |
SHOULDER ARTHROPLASTY |
3 |
0.0011 |
| 185 |
INSURANCE ISSUE |
17 |
0.0011 |
| 186 |
FACIAL BONES FRACTURE |
4 |
0.0011 |
| 187 |
THROMBOCYTOSIS |
4 |
0.0011 |
| 188 |
EMPHYSEMA |
11 |
0.0011 |
| 189 |
IRON DEFICIENCY ANAEMIA |
10 |
0.0011 |
| 190 |
APHONIA |
15 |
0.0011 |
| 191 |
ENDOTRACHEAL INTUBATION |
3 |
0.0011 |
| 192 |
POLYP |
7 |
0.0011 |
| 193 |
ILLNESS |
109 |
0.0011 |
| 194 |
BRONCHOSPASM |
15 |
0.0011 |
| 195 |
WHEEZING |
62 |
0.0010 |
| 196 |
END STAGE RENAL DISEASE |
19 |
0.0010 |
| 197 |
HYPERTONIC BLADDER |
3 |
0.0010 |
| 198 |
REHABILITATION THERAPY |
4 |
0.0010 |
| 199 |
ORGANISING PNEUMONIA |
5 |
0.0010 |
| 200 |
GASTROINTESTINAL INFECTION |
9 |
0.0010 |
| 201 |
ATYPICAL PNEUMONIA |
3 |
0.0010 |
| 202 |
PNEUMONIA |
324 |
0.0010 |
| 203 |
METABOLIC ENCEPHALOPATHY |
3 |
0.0010 |
| 204 |
REBOUND ACID HYPERSECRETION |
3 |
0.0010 |
| 205 |
VIRAL INFECTION |
33 |
0.0010 |
| 206 |
FUNGAL SKIN INFECTION |
4 |
0.0010 |
| 207 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
6 |
0.0010 |
| 208 |
DYSPNOEA EXERTIONAL |
37 |
0.0010 |
| 209 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
3 |
0.0010 |
| 210 |
HAEMOPTYSIS |
27 |
0.0010 |
| 211 |
DERMATITIS CONTACT |
11 |
0.0010 |
| 212 |
INFUSION SITE EXTRAVASATION |
6 |
0.0010 |
| 213 |
BRAIN FOG |
15 |
0.0010 |
| 214 |
ELECTROENCEPHALOGRAM ABNORMAL |
3 |
0.0009 |
| 215 |
PNEUMOTHORAX |
15 |
0.0009 |
| 216 |
COUGH |
265 |
0.0009 |
| 217 |
TONGUE DISCOMFORT |
4 |
0.0009 |
| 218 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
16 |
0.0009 |
| 219 |
DYSPHONIA |
55 |
0.0009 |
| 220 |
CUSHINGOID |
3 |
0.0009 |
| 221 |
DEVICE OPERATIONAL ISSUE |
4 |
0.0009 |
| 222 |
DECREASED ACTIVITY |
10 |
0.0009 |
| 223 |
MUSCLE STRAIN |
8 |
0.0009 |
| 224 |
HORDEOLUM |
4 |
0.0009 |
| 225 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 226 |
PHARYNGEAL SWELLING |
9 |
0.0009 |
| 227 |
ASPIRATION |
10 |
0.0009 |
| 228 |
FOOD ALLERGY |
7 |
0.0009 |
| 229 |
APPETITE DISORDER |
6 |
0.0009 |
| 230 |
CONCUSSION |
7 |
0.0009 |
| 231 |
PRODUCT ADMINISTRATION INTERRUPTED |
7 |
0.0009 |
| 232 |
PRODUCT LEAKAGE |
5 |
0.0009 |
| 233 |
EYE INFECTION |
10 |
0.0009 |
| 234 |
NASAL DISCOMFORT |
7 |
0.0009 |
| 235 |
HAEMOGLOBIN INCREASED |
4 |
0.0009 |
| 236 |
DISEASE COMPLICATION |
4 |
0.0009 |
| 237 |
EAR DISORDER |
4 |
0.0009 |
| 238 |
PULMONARY MASS |
13 |
0.0009 |
| 239 |
RESPIRATORY DISTRESS |
24 |
0.0009 |
| 240 |
HYPOPNOEA |
3 |
0.0009 |
| 241 |
HYPOXIA |
30 |
0.0009 |
| 242 |
DECREASED INTEREST |
5 |
0.0008 |
| 243 |
COVID-19 PNEUMONIA |
10 |
0.0008 |
| 244 |
BACTERAEMIA |
10 |
0.0008 |
| 245 |
CHRONIC KIDNEY DISEASE |
64 |
0.0008 |
| 246 |
WRIST FRACTURE |
10 |
0.0008 |
| 247 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
33 |
0.0008 |
| 248 |
SPONDYLITIS |
3 |
0.0008 |
| 249 |
ORAL HERPES |
16 |
0.0008 |
| 250 |
DYSPNOEA |
461 |
0.0008 |
| 251 |
ARTHROPOD BITE |
6 |
0.0008 |
| 252 |
HYPERVOLAEMIA |
4 |
0.0008 |
| 253 |
SINUS DISORDER |
16 |
0.0008 |
| 254 |
SCOLIOSIS |
5 |
0.0008 |
| 255 |
IMPAIRED GASTRIC EMPTYING |
11 |
0.0008 |
| 256 |
BLOOD PRESSURE ABNORMAL |
16 |
0.0008 |
| 257 |
LUNG DISORDER |
39 |
0.0008 |
| 258 |
SNORING |
3 |
0.0008 |
| 259 |
FOOT FRACTURE |
15 |
0.0008 |
| 260 |
VENTRICULAR TACHYCARDIA |
13 |
0.0008 |
| 261 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
3 |
0.0008 |
| 262 |
ABDOMINAL INFECTION |
2 |
0.0008 |
| 263 |
THROAT IRRITATION |
35 |
0.0008 |
| 264 |
EAR DISCOMFORT |
8 |
0.0008 |
| 265 |
OESOPHAGEAL DISORDER |
3 |
0.0008 |
| 266 |
OROPHARYNGEAL DISCOMFORT |
7 |
0.0008 |
| 267 |
CARDIAC FLUTTER |
5 |
0.0008 |
| 268 |
POOR VENOUS ACCESS |
8 |
0.0008 |
| 269 |
PULMONARY HAEMORRHAGE |
6 |
0.0008 |
| 270 |
SNEEZING |
17 |
0.0008 |
| 271 |
MUSCULOSKELETAL DISCOMFORT |
13 |
0.0008 |
| 272 |
CHEST DISCOMFORT |
77 |
0.0008 |
| 273 |
ELECTROCARDIOGRAM QT PROLONGED |
27 |
0.0007 |
| 274 |
COMPRESSION FRACTURE |
4 |
0.0007 |
| 275 |
GINGIVITIS |
4 |
0.0007 |
| 276 |
HEART RATE INCREASED |
73 |
0.0007 |
| 277 |
TACHYPNOEA |
10 |
0.0007 |
| 278 |
PERIPHERAL VENOUS DISEASE |
3 |
0.0007 |
| 279 |
SMALL INTESTINAL OBSTRUCTION |
9 |
0.0007 |
| 280 |
SUPRAVENTRICULAR TACHYCARDIA |
7 |
0.0007 |
| 281 |
DEVICE DELIVERY SYSTEM ISSUE |
20 |
0.0007 |
| 282 |
RIB FRACTURE |
15 |
0.0007 |
| 283 |
UPPER-AIRWAY COUGH SYNDROME |
6 |
0.0007 |
| 284 |
SPINAL COMPRESSION FRACTURE |
6 |
0.0007 |
| 285 |
RESPIRATION ABNORMAL |
5 |
0.0007 |
| 286 |
SOCIAL PROBLEM |
3 |
0.0007 |
| 287 |
EAR PAIN |
14 |
0.0007 |
| 288 |
LEUKOCYTOSIS |
13 |
0.0007 |
| 289 |
HEART RATE ABNORMAL |
4 |
0.0007 |
| 290 |
OROPHARYNGEAL PAIN |
66 |
0.0007 |
| 291 |
SLEEP TERROR |
3 |
0.0007 |
| 292 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
3 |
0.0007 |
| 293 |
LIGAMENT SPRAIN |
7 |
0.0007 |
| 294 |
COGNITIVE DISORDER |
33 |
0.0007 |
| 295 |
INTENTIONAL DOSE OMISSION |
20 |
0.0007 |
| 296 |
NASAL CONGESTION |
41 |
0.0007 |
| 297 |
BACTERIAL INFECTION |
13 |
0.0007 |
| 298 |
EXERCISE TOLERANCE DECREASED |
4 |
0.0007 |
| 299 |
TOOTH INJURY |
3 |
0.0007 |
| 300 |
URINE OUTPUT DECREASED |
6 |
0.0007 |
| 301 |
DYSPHEMIA |
3 |
0.0007 |
| 302 |
SPINAL OSTEOARTHRITIS |
6 |
0.0007 |
| 303 |
FEELING OF BODY TEMPERATURE CHANGE |
4 |
0.0007 |
| 304 |
COVID-19 |
119 |
0.0007 |
| 305 |
WHEELCHAIR USER |
3 |
0.0007 |
| 306 |
HYPERLIPIDAEMIA |
8 |
0.0007 |
| 307 |
WEIGHT FLUCTUATION |
7 |
0.0007 |
| 308 |
SYMPTOM RECURRENCE |
4 |
0.0007 |
| 309 |
MENINGITIS ASEPTIC |
3 |
0.0007 |
| 310 |
ANAL INCONTINENCE |
6 |
0.0007 |
| 311 |
THROAT TIGHTNESS |
18 |
0.0007 |
| 312 |
VASCULAR DEVICE INFECTION |
3 |
0.0007 |
| 313 |
INJECTION SITE VESICLES |
4 |
0.0007 |
| 314 |
OSTEOPENIA |
10 |
0.0007 |
| 315 |
HEREDITARY ANGIOEDEMA |
7 |
0.0007 |
| 316 |
ORAL DISCOMFORT |
9 |
0.0006 |
| 317 |
PHARYNGITIS STREPTOCOCCAL |
7 |
0.0006 |
| 318 |
BRONCHOPULMONARY ASPERGILLOSIS |
5 |
0.0006 |
| 319 |
RESPIRATORY FAILURE |
47 |
0.0006 |
| 320 |
HOSPITALISATION |
99 |
0.0006 |
| 321 |
ROSACEA |
3 |
0.0006 |
| 322 |
SKIN LACERATION |
7 |
0.0006 |
| 323 |
HEPATIC ENCEPHALOPATHY |
6 |
0.0006 |
| 324 |
PELVIC FRACTURE |
5 |
0.0006 |
| 325 |
CLOSTRIDIUM DIFFICILE INFECTION |
14 |
0.0006 |
| 326 |
PRE-EXISTING CONDITION IMPROVED |
4 |
0.0006 |
| 327 |
RENAL INJURY |
19 |
0.0006 |
| 328 |
GASTROINTESTINAL INFLAMMATION |
5 |
0.0006 |
| 329 |
ARTERIOSCLEROSIS |
6 |
0.0006 |
| 330 |
RESPIRATORY DISORDER |
19 |
0.0006 |
| 331 |
SARCOIDOSIS |
3 |
0.0006 |
| 332 |
ATRIAL FLUTTER |
5 |
0.0006 |
| 333 |
PULMONARY HYPERTENSION |
13 |
0.0006 |
| 334 |
SEIZURE |
72 |
0.0006 |
| 335 |
OBSESSIVE-COMPULSIVE DISORDER |
5 |
0.0006 |
| 336 |
INFECTION |
89 |
0.0006 |
| 337 |
ASPHYXIA |
5 |
0.0006 |
| 338 |
INFLUENZA |
68 |
0.0006 |
| 339 |
MUCOUS STOOLS |
3 |
0.0006 |
| 340 |
DRY EYE |
30 |
0.0006 |
| 341 |
VEIN DISORDER |
3 |
0.0006 |
| 342 |
HYPOAESTHESIA ORAL |
9 |
0.0006 |
| 343 |
GASTROOESOPHAGEAL REFLUX DISEASE |
48 |
0.0006 |
| 344 |
EYE PRURITUS |
20 |
0.0006 |
| 345 |
BALANCE DISORDER |
51 |
0.0006 |
| 346 |
FACIAL PARALYSIS |
5 |
0.0006 |
| 347 |
INITIAL INSOMNIA |
6 |
0.0006 |
| 348 |
CARDIAC OPERATION |
5 |
0.0006 |
| 349 |
BENIGN PROSTATIC HYPERPLASIA |
3 |
0.0006 |
| 350 |
LYMPHOEDEMA |
4 |
0.0006 |
| 351 |
FEELING JITTERY |
11 |
0.0006 |
| 352 |
ADRENAL INSUFFICIENCY |
7 |
0.0006 |
| 353 |
TENDERNESS |
6 |
0.0006 |
| 354 |
MALABSORPTION |
3 |
0.0006 |
| 355 |
PRODUCT ODOUR ABNORMAL |
6 |
0.0006 |
| 356 |
TRANSFUSION |
6 |
0.0006 |
| 357 |
RIGHT VENTRICULAR FAILURE |
4 |
0.0006 |
| 358 |
FUNGAL INFECTION |
19 |
0.0006 |
| 359 |
BLOOD LACTIC ACID INCREASED |
3 |
0.0006 |
| 360 |
SPINAL OPERATION |
7 |
0.0006 |
| 361 |
GENERALISED OEDEMA |
7 |
0.0006 |
| 362 |
OBESITY |
9 |
0.0006 |
| 363 |
DIVERTICULUM |
4 |
0.0006 |
| 364 |
BODY HEIGHT DECREASED |
6 |
0.0006 |
| 365 |
PARAESTHESIA ORAL |
8 |
0.0006 |
| 366 |
BEHAVIOUR DISORDER |
3 |
0.0006 |
| 367 |
GASTROENTERITIS VIRAL |
10 |
0.0006 |
| 368 |
UPPER LIMB FRACTURE |
11 |
0.0006 |
| 369 |
PULMONARY ARTERIAL HYPERTENSION |
8 |
0.0006 |
| 370 |
PULMONARY THROMBOSIS |
6 |
0.0005 |
| 371 |
FLUID OVERLOAD |
8 |
0.0005 |
| 372 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
39 |
0.0005 |
| 373 |
EXOSTOSIS |
5 |
0.0005 |
| 374 |
ASTHENOPIA |
3 |
0.0005 |
| 375 |
ANAPHYLACTIC REACTION |
30 |
0.0005 |
| 376 |
SENSITIVE SKIN |
4 |
0.0005 |
| 377 |
STREPTOCOCCAL INFECTION |
3 |
0.0005 |
| 378 |
IMMUNODEFICIENCY |
8 |
0.0005 |
| 379 |
EPISTAXIS |
40 |
0.0005 |
| 380 |
THERAPY INTERRUPTED |
38 |
0.0005 |
| 381 |
PULMONARY CONGESTION |
7 |
0.0005 |
| 382 |
FLUID RETENTION |
27 |
0.0005 |
| 383 |
TENDON PAIN |
4 |
0.0005 |
| 384 |
ATRIAL FIBRILLATION |
51 |
0.0005 |
| 385 |
BOWEL MOVEMENT IRREGULARITY |
4 |
0.0005 |
| 386 |
LOWER LIMB FRACTURE |
10 |
0.0005 |
| 387 |
PRODUCT TASTE ABNORMAL |
7 |
0.0005 |
| 388 |
PRODUCT DOSE OMISSION ISSUE |
152 |
0.0005 |
| 389 |
MUSCULOSKELETAL CHEST PAIN |
8 |
0.0005 |
| 390 |
RETCHING |
11 |
0.0005 |
| 391 |
DIZZINESS POSTURAL |
5 |
0.0005 |
| 392 |
LIMB INJURY |
14 |
0.0005 |
| 393 |
MOBILITY DECREASED |
37 |
0.0005 |
| 394 |
HYPOVOLAEMIA |
3 |
0.0005 |
| 395 |
CHOKING |
10 |
0.0005 |
| 396 |
KIDNEY INFECTION |
10 |
0.0005 |
| 397 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
11 |
0.0005 |
| 398 |
BLOOD IRON DECREASED |
6 |
0.0005 |
| 399 |
BLADDER DISORDER |
5 |
0.0005 |
| 400 |
INABILITY TO AFFORD MEDICATION |
5 |
0.0005 |
| 401 |
MACULAR DEGENERATION |
6 |
0.0005 |
| 402 |
MUSCULAR WEAKNESS |
57 |
0.0005 |
| 403 |
SALIVARY HYPERSECRETION |
5 |
0.0005 |
| 404 |
SPINAL FRACTURE |
10 |
0.0005 |
| 405 |
BRAIN INJURY |
5 |
0.0005 |
| 406 |
POOR QUALITY DEVICE USED |
5 |
0.0005 |
| 407 |
TYPE 1 DIABETES MELLITUS |
3 |
0.0005 |
| 408 |
RENAL FAILURE |
66 |
0.0005 |
| 409 |
CONSTIPATION |
108 |
0.0005 |
| 410 |
PRODUCT DOSE OMISSION IN ERROR |
14 |
0.0005 |
| 411 |
DERMATITIS ACNEIFORM |
3 |
0.0005 |
| 412 |
PLEURAL EFFUSION |
30 |
0.0005 |
| 413 |
TENSION |
3 |
0.0005 |
| 414 |
URINARY TRACT INFECTION |
84 |
0.0005 |
| 415 |
EYELID PTOSIS |
5 |
0.0005 |
| 416 |
THERAPY NON-RESPONDER |
22 |
0.0005 |
| 417 |
ABNORMAL FAECES |
4 |
0.0005 |
| 418 |
LARYNGEAL OEDEMA |
3 |
0.0005 |
| 419 |
OSTEOPOROSIS |
20 |
0.0005 |
| 420 |
PIGMENTATION DISORDER |
3 |
0.0005 |
| 421 |
TEMPERATURE INTOLERANCE |
5 |
0.0005 |
| 422 |
TACHYCARDIA |
43 |
0.0005 |
| 423 |
COMPLICATION ASSOCIATED WITH DEVICE |
7 |
0.0005 |
| 424 |
EYE DISCHARGE |
5 |
0.0005 |
| 425 |
EPSTEIN-BARR VIRUS INFECTION |
3 |
0.0005 |
| 426 |
GASTROENTERITIS |
7 |
0.0005 |
| 427 |
PETECHIAE |
5 |
0.0005 |
| 428 |
BLOOD SODIUM DECREASED |
9 |
0.0005 |
| 429 |
KNEE ARTHROPLASTY |
10 |
0.0005 |
| 430 |
HEAD INJURY |
15 |
0.0005 |
| 431 |
HYPOTENSION |
95 |
0.0005 |
| 432 |
INCONTINENCE |
5 |
0.0005 |
| 433 |
CLOSTRIDIUM DIFFICILE COLITIS |
5 |
0.0005 |
| 434 |
HYPOTHYROIDISM |
15 |
0.0005 |
| 435 |
EATING DISORDER |
10 |
0.0005 |
| 436 |
PULMONARY FIBROSIS |
9 |
0.0005 |
| 437 |
DIVERTICULITIS |
13 |
0.0005 |
| 438 |
JOINT INJURY |
10 |
0.0005 |
| 439 |
SCAR |
8 |
0.0005 |
| 440 |
HAEMOGLOBIN ABNORMAL |
3 |
0.0005 |
| 441 |
SKIN HYPERPIGMENTATION |
4 |
0.0005 |
| 442 |
BLOOD MAGNESIUM DECREASED |
4 |
0.0005 |
| 443 |
HIATUS HERNIA |
6 |
0.0005 |
| 444 |
HERPES SIMPLEX |
3 |
0.0005 |
| 445 |
MIGRAINE |
44 |
0.0005 |
| 446 |
SKIN SWELLING |
4 |
0.0005 |
| 447 |
CARDIAC FAILURE CONGESTIVE |
37 |
0.0005 |
| 448 |
NEPHROLITHIASIS |
21 |
0.0005 |
| 449 |
STAPHYLOCOCCAL INFECTION |
15 |
0.0005 |
| 450 |
LUNG INFILTRATION |
4 |
0.0005 |
| 451 |
ARTERIOSCLEROSIS CORONARY ARTERY |
3 |
0.0005 |
| 452 |
PALPITATIONS |
53 |
0.0005 |
| 453 |
ABDOMINAL ABSCESS |
2 |
0.0005 |
| 454 |
LUNG INFECTION |
7 |
0.0005 |
| 455 |
CARDIAC FAILURE ACUTE |
3 |
0.0004 |
| 456 |
FACIAL PAIN |
4 |
0.0004 |
| 457 |
POST-TRAUMATIC STRESS DISORDER |
3 |
0.0004 |
| 458 |
QUALITY OF LIFE DECREASED |
6 |
0.0004 |
| 459 |
MALNUTRITION |
5 |
0.0004 |
| 460 |
BREAST MASS |
3 |
0.0004 |
| 461 |
SKIN INFECTION |
5 |
0.0004 |
| 462 |
ACUTE KIDNEY INJURY |
68 |
0.0004 |
| 463 |
STATUS EPILEPTICUS |
5 |
0.0004 |
| 464 |
PNEUMONIA ASPIRATION |
11 |
0.0004 |
| 465 |
SLEEP DISORDER |
31 |
0.0004 |
| 466 |
EYE MOVEMENT DISORDER |
3 |
0.0004 |
| 467 |
JOINT EFFUSION |
3 |
0.0004 |
| 468 |
NERVE COMPRESSION |
4 |
0.0004 |
| 469 |
PERICARDIAL EFFUSION |
10 |
0.0004 |
| 470 |
INTERVERTEBRAL DISC DEGENERATION |
4 |
0.0004 |
| 471 |
CHEST PAIN |
80 |
0.0004 |
| 472 |
PRODUCT DISTRIBUTION ISSUE |
4 |
0.0004 |
| 473 |
CONJUNCTIVITIS |
8 |
0.0004 |
| 474 |
BLOOD POTASSIUM INCREASED |
7 |
0.0004 |
| 475 |
SEPSIS |
48 |
0.0004 |
| 476 |
ELECTROLYTE IMBALANCE |
5 |
0.0004 |
| 477 |
NASOPHARYNGITIS |
79 |
0.0004 |
| 478 |
NEPHROPATHY |
4 |
0.0004 |
| 479 |
MULTIPLE FRACTURES |
7 |
0.0004 |
| 480 |
PAPULE |
3 |
0.0004 |
| 481 |
SQUAMOUS CELL CARCINOMA |
4 |
0.0004 |
| 482 |
GASTROINTESTINAL DISORDER |
38 |
0.0004 |
| 483 |
SINUS TACHYCARDIA |
6 |
0.0004 |
| 484 |
PRODUCT PACKAGING ISSUE |
4 |
0.0004 |
| 485 |
PRODUCT SUPPLY ISSUE |
3 |
0.0004 |
| 486 |
CATARACT |
25 |
0.0004 |
| 487 |
DRY MOUTH |
34 |
0.0004 |
| 488 |
CONTUSION |
40 |
0.0004 |
| 489 |
FALL |
138 |
0.0004 |
| 490 |
LOCALISED INFECTION |
10 |
0.0004 |
| 491 |
HYPOKALAEMIA |
19 |
0.0004 |
| 492 |
LIQUID PRODUCT PHYSICAL ISSUE |
3 |
0.0004 |
| 493 |
TREMOR |
68 |
0.0004 |
| 494 |
HEPATOMEGALY |
4 |
0.0004 |
| 495 |
BLINDNESS TRANSIENT |
3 |
0.0004 |
| 496 |
HYPOPHOSPHATAEMIA |
3 |
0.0004 |
| 497 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0004 |
| 498 |
HOSPICE CARE |
4 |
0.0004 |
| 499 |
HYPERCALCAEMIA |
5 |
0.0004 |
| 500 |
DRUG EFFECT LESS THAN EXPECTED |
6 |
0.0004 |
| 501 |
PHARYNGITIS |
5 |
0.0004 |
| 502 |
ABDOMINAL TENDERNESS |
2 |
0.0004 |
| 503 |
EYE IRRITATION |
23 |
0.0004 |
| 504 |
PROCEDURAL PAIN |
11 |
0.0004 |
| 505 |
TASTE DISORDER |
8 |
0.0004 |
| 506 |
TROPONIN INCREASED |
3 |
0.0004 |
| 507 |
DEMENTIA |
11 |
0.0004 |
| 508 |
DRY THROAT |
4 |
0.0004 |
| 509 |
ABDOMINAL DISTENSION |
41 |
0.0004 |
| 510 |
SLUGGISHNESS |
4 |
0.0004 |
| 511 |
THERAPEUTIC RESPONSE SHORTENED |
13 |
0.0004 |
| 512 |
LIPASE INCREASED |
3 |
0.0004 |
| 513 |
RENAL FAILURE CHRONIC |
3 |
0.0004 |
| 514 |
ATRIOVENTRICULAR BLOCK |
3 |
0.0004 |
| 515 |
PRODUCT USE IN UNAPPROVED INDICATION |
96 |
0.0004 |
| 516 |
EXPOSURE VIA SKIN CONTACT |
10 |
0.0004 |
| 517 |
RESTLESS LEGS SYNDROME |
7 |
0.0004 |
| 518 |
NODULE |
5 |
0.0004 |
| 519 |
ELECTROCARDIOGRAM ABNORMAL |
3 |
0.0004 |
| 520 |
CYANOSIS |
6 |
0.0004 |
| 521 |
PRODUCT USE COMPLAINT |
6 |
0.0004 |
| 522 |
ANHEDONIA |
10 |
0.0004 |
| 523 |
TOOTH INFECTION |
5 |
0.0004 |
| 524 |
RENAL CYST |
3 |
0.0004 |
| 525 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
68 |
0.0004 |
| 526 |
CYSTITIS |
12 |
0.0004 |
| 527 |
TUBULOINTERSTITIAL NEPHRITIS |
7 |
0.0004 |
| 528 |
MALIGNANT MELANOMA |
5 |
0.0004 |
| 529 |
SENSORY LOSS |
3 |
0.0004 |
| 530 |
RHINITIS |
3 |
0.0004 |
| 531 |
MYASTHENIA GRAVIS |
3 |
0.0004 |
| 532 |
RHINORRHOEA |
24 |
0.0004 |
| 533 |
POST PROCEDURAL INFECTION |
3 |
0.0004 |
| 534 |
DECUBITUS ULCER |
3 |
0.0004 |
| 535 |
PNEUMONITIS |
10 |
0.0004 |
| 536 |
SLEEP APNOEA SYNDROME |
7 |
0.0004 |
| 537 |
ESCHERICHIA INFECTION |
3 |
0.0004 |
| 538 |
LACRIMATION INCREASED |
11 |
0.0004 |
| 539 |
MELAENA |
8 |
0.0004 |
| 540 |
ACUTE CORONARY SYNDROME |
3 |
0.0004 |
| 541 |
DENTAL CARIES |
4 |
0.0004 |
| 542 |
FOOT DEFORMITY |
4 |
0.0004 |
| 543 |
THROMBOSIS |
29 |
0.0004 |
| 544 |
NERVE INJURY |
4 |
0.0004 |
| 545 |
DRY SKIN |
48 |
0.0004 |
| 546 |
OBSTRUCTIVE AIRWAYS DISORDER |
4 |
0.0004 |
| 547 |
GAIT INABILITY |
12 |
0.0004 |
| 548 |
GASTROINTESTINAL HAEMORRHAGE |
30 |
0.0004 |
| 549 |
SURGERY |
21 |
0.0004 |
| 550 |
ORAL PAIN |
8 |
0.0004 |
| 551 |
FACE OEDEMA |
6 |
0.0004 |
| 552 |
BLINDNESS UNILATERAL |
5 |
0.0004 |
| 553 |
BLOOD PRESSURE INCREASED |
54 |
0.0004 |
| 554 |
CARDIAC DISORDER |
33 |
0.0004 |
| 555 |
SWOLLEN TONGUE |
11 |
0.0004 |
| 556 |
VITAMIN D DECREASED |
3 |
0.0004 |
| 557 |
HAEMATURIA |
12 |
0.0004 |
| 558 |
INTERNAL HAEMORRHAGE |
4 |
0.0003 |
| 559 |
SKIN DISCOLOURATION |
16 |
0.0003 |
| 560 |
HERPES ZOSTER |
20 |
0.0003 |
| 561 |
DRUG INTERACTION |
55 |
0.0003 |
| 562 |
HYSTERECTOMY |
3 |
0.0003 |
| 563 |
DEHYDRATION |
46 |
0.0003 |
| 564 |
OEDEMA PERIPHERAL |
42 |
0.0003 |
| 565 |
BACK PAIN |
80 |
0.0003 |
| 566 |
METABOLIC ACIDOSIS |
11 |
0.0003 |
| 567 |
DEVICE USE ISSUE |
6 |
0.0003 |
| 568 |
HEART RATE DECREASED |
12 |
0.0003 |
| 569 |
CHILLS |
40 |
0.0003 |
| 570 |
NECK PAIN |
19 |
0.0003 |
| 571 |
ABDOMINAL DISCOMFORT |
57 |
0.0003 |
| 572 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
6 |
0.0003 |
| 573 |
RESPIRATORY RATE INCREASED |
3 |
0.0003 |
| 574 |
CELLULITIS |
17 |
0.0003 |
| 575 |
EYE PAIN |
19 |
0.0003 |
| 576 |
CARDIAC FAILURE |
27 |
0.0003 |
| 577 |
THIRST |
6 |
0.0003 |
| 578 |
FLATULENCE |
19 |
0.0003 |
| 579 |
CARDIO-RESPIRATORY ARREST |
14 |
0.0003 |
| 580 |
EYE DISORDER |
11 |
0.0003 |
| 581 |
GOUT |
6 |
0.0003 |
| 582 |
INFUSION RELATED REACTION |
22 |
0.0003 |
| 583 |
SWELLING |
31 |
0.0003 |
| 584 |
UNEVALUABLE EVENT |
25 |
0.0003 |
| 585 |
LIP SWELLING |
11 |
0.0003 |
| 586 |
LIP DRY |
3 |
0.0003 |
| 587 |
PELVIC PAIN |
6 |
0.0003 |
| 588 |
WEIGHT DECREASED |
92 |
0.0003 |
| 589 |
HYPERSENSITIVITY |
61 |
0.0003 |
| 590 |
FATIGUE |
255 |
0.0003 |
| 591 |
IRRITABLE BOWEL SYNDROME |
7 |
0.0003 |
| 592 |
RESPIRATORY DEPRESSION |
4 |
0.0003 |
| 593 |
DEVICE RELATED INFECTION |
5 |
0.0003 |
| 594 |
FEELING COLD |
9 |
0.0003 |
| 595 |
CYST |
4 |
0.0003 |
| 596 |
ILEUS |
4 |
0.0003 |
| 597 |
PRODUCT PRESCRIBING ISSUE |
7 |
0.0003 |
| 598 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 599 |
VISION BLURRED |
44 |
0.0003 |
| 600 |
INTESTINAL OBSTRUCTION |
12 |
0.0003 |
| 601 |
COLITIS |
12 |
0.0003 |
| 602 |
DYSPEPSIA |
31 |
0.0003 |
| 603 |
EYE INFLAMMATION |
3 |
0.0003 |
| 604 |
HYPERKALAEMIA |
11 |
0.0003 |
| 605 |
SCIATICA |
5 |
0.0003 |
| 606 |
ABSCESS |
5 |
0.0003 |
| 607 |
INTRAOCULAR PRESSURE INCREASED |
4 |
0.0003 |
| 608 |
PYREXIA |
108 |
0.0003 |
| 609 |
DEPRESSION |
71 |
0.0003 |
| 610 |
HYPERTENSION |
66 |
0.0003 |
| 611 |
ROTATOR CUFF SYNDROME |
4 |
0.0003 |
| 612 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 613 |
HEADACHE |
195 |
0.0003 |
| 614 |
HYPERCHOLESTEROLAEMIA |
3 |
0.0003 |
| 615 |
CHROMATURIA |
7 |
0.0003 |
| 616 |
NEEDLE ISSUE |
9 |
0.0003 |
| 617 |
DYSSTASIA |
9 |
0.0003 |
| 618 |
INSOMNIA |
82 |
0.0003 |
| 619 |
AUTOIMMUNE DISORDER |
3 |
0.0003 |
| 620 |
RENAL TUBULAR NECROSIS |
3 |
0.0003 |
| 621 |
DECREASED IMMUNE RESPONSIVENESS |
3 |
0.0003 |
| 622 |
VITREOUS FLOATERS |
3 |
0.0003 |
| 623 |
SHOCK |
7 |
0.0003 |
| 624 |
BEDRIDDEN |
4 |
0.0003 |
| 625 |
MUSCLE TWITCHING |
7 |
0.0003 |
| 626 |
DERMATITIS ATOPIC |
16 |
0.0003 |
| 627 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0003 |
| 628 |
PANIC ATTACK |
11 |
0.0003 |
| 629 |
BLOOD POTASSIUM DECREASED |
9 |
0.0003 |
| 630 |
CORONARY ARTERY DISEASE |
9 |
0.0003 |
| 631 |
DECREASED APPETITE |
69 |
0.0003 |
| 632 |
DYSGEUSIA |
22 |
0.0003 |
| 633 |
EYE SWELLING |
11 |
0.0003 |
| 634 |
PRODUCT SUBSTITUTION ISSUE |
17 |
0.0003 |
| 635 |
OEDEMA |
16 |
0.0003 |
| 636 |
PRURITUS |
113 |
0.0003 |
| 637 |
FEELING HOT |
18 |
0.0003 |
| 638 |
MOOD ALTERED |
8 |
0.0003 |
| 639 |
NEUTROPHIL COUNT INCREASED |
3 |
0.0003 |
| 640 |
PRODUCT USE ISSUE |
55 |
0.0003 |
| 641 |
CORONARY ARTERY OCCLUSION |
4 |
0.0003 |
| 642 |
BLOOD PRESSURE FLUCTUATION |
7 |
0.0003 |
| 643 |
THERAPEUTIC RESPONSE UNEXPECTED |
13 |
0.0003 |
| 644 |
HYPOGLYCAEMIA |
14 |
0.0003 |
| 645 |
CARPAL TUNNEL SYNDROME |
4 |
0.0003 |
| 646 |
NEUROTOXICITY |
5 |
0.0003 |
| 647 |
EOSINOPHILIA |
5 |
0.0003 |
| 648 |
BLISTER |
16 |
0.0003 |
| 649 |
PAIN |
175 |
0.0003 |
| 650 |
JOINT DISLOCATION |
3 |
0.0003 |
| 651 |
FEELING ABNORMAL |
68 |
0.0003 |
| 652 |
PAIN IN JAW |
8 |
0.0003 |
| 653 |
DRUG ERUPTION |
5 |
0.0003 |
| 654 |
AGEUSIA |
7 |
0.0003 |
| 655 |
HIP FRACTURE |
9 |
0.0003 |
| 656 |
RED BLOOD CELL COUNT DECREASED |
8 |
0.0003 |
| 657 |
CONDITION AGGRAVATED |
85 |
0.0003 |
| 658 |
PARALYSIS |
4 |
0.0003 |
| 659 |
ASTHENIA |
105 |
0.0003 |
| 660 |
ANGINA PECTORIS |
8 |
0.0003 |
| 661 |
HYPERSOMNIA |
8 |
0.0003 |
| 662 |
RENAL DISORDER |
13 |
0.0003 |
| 663 |
SKIN CANCER |
6 |
0.0003 |
| 664 |
DISCOMFORT |
17 |
0.0003 |
| 665 |
ABDOMINAL PAIN UPPER |
57 |
0.0003 |
| 666 |
ABDOMINAL PAIN LOWER |
7 |
0.0003 |
| 667 |
RASH PRURITIC |
15 |
0.0003 |
| 668 |
FAECES DISCOLOURED |
6 |
0.0003 |
| 669 |
DIZZINESS |
138 |
0.0003 |
| 670 |
SWELLING FACE |
18 |
0.0003 |
| 671 |
BACK INJURY |
3 |
0.0003 |
| 672 |
SEPTIC SHOCK |
12 |
0.0003 |
| 673 |
PRODUCT DISPENSING ERROR |
6 |
0.0003 |
| 674 |
URTICARIA |
46 |
0.0003 |
| 675 |
INTERVERTEBRAL DISC PROTRUSION |
6 |
0.0003 |
| 676 |
CHOLELITHIASIS |
9 |
0.0003 |
| 677 |
HYPERGLYCAEMIA |
10 |
0.0003 |
| 678 |
VISUAL IMPAIRMENT |
34 |
0.0003 |
| 679 |
ANXIETY |
78 |
0.0003 |
| 680 |
OCULAR HYPERAEMIA |
13 |
0.0003 |
| 681 |
ERYTHEMA |
56 |
0.0003 |
| 682 |
ASCITES |
8 |
0.0003 |
| 683 |
TOOTH FRACTURE |
3 |
0.0003 |
| 684 |
RASH ERYTHEMATOUS |
13 |
0.0003 |
| 685 |
ARTHRALGIA |
113 |
0.0003 |
| 686 |
EXPIRED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 687 |
BLOOD GLUCOSE ABNORMAL |
5 |
0.0003 |
| 688 |
CARDIOMYOPATHY |
4 |
0.0003 |
| 689 |
SKIN DISORDER |
9 |
0.0003 |
| 690 |
HYPERTENSIVE CRISIS |
3 |
0.0003 |
| 691 |
DIARRHOEA |
174 |
0.0003 |
| 692 |
GLOSSODYNIA |
6 |
0.0003 |
| 693 |
PULMONARY OEDEMA |
12 |
0.0003 |
| 694 |
MIDDLE INSOMNIA |
5 |
0.0003 |
| 695 |
DEAFNESS |
7 |
0.0003 |
| 696 |
ARTHRITIS |
21 |
0.0003 |
| 697 |
MALAISE |
117 |
0.0003 |
| 698 |
HEPATIC CIRRHOSIS |
5 |
0.0003 |
| 699 |
HEART RATE IRREGULAR |
6 |
0.0003 |
| 700 |
ECONOMIC PROBLEM |
4 |
0.0003 |
| 701 |
OFF LABEL USE |
231 |
0.0003 |
| 702 |
POLLAKIURIA |
11 |
0.0003 |
| 703 |
ASPARTATE AMINOTRANSFERASE INCREASED |
14 |
0.0003 |
| 704 |
DYSPHAGIA |
25 |
0.0003 |
| 705 |
HAEMOGLOBIN DECREASED |
27 |
0.0003 |
| 706 |
NEUROPATHY PERIPHERAL |
25 |
0.0003 |
| 707 |
MEMORY IMPAIRMENT |
36 |
0.0003 |
| 708 |
INJECTION SITE RASH |
8 |
0.0003 |
| 709 |
LETHARGY |
15 |
0.0003 |
| 710 |
WHITE BLOOD CELL COUNT INCREASED |
10 |
0.0003 |
| 711 |
POST PROCEDURAL COMPLICATION |
5 |
0.0003 |
| 712 |
SYNCOPE |
26 |
0.0003 |
| 713 |
PERIPHERAL SWELLING |
40 |
0.0003 |
| 714 |
OSTEOARTHRITIS |
11 |
0.0003 |
| 715 |
RENAL FAILURE ACUTE |
11 |
0.0003 |
| 716 |
WEIGHT INCREASED |
58 |
0.0003 |
| 717 |
ANKLE FRACTURE |
4 |
0.0003 |
| 718 |
VOMITING |
121 |
0.0003 |
| 719 |
DEVICE MALFUNCTION |
18 |
0.0003 |
| 720 |
SPINAL PAIN |
3 |
0.0003 |
| 721 |
LYMPHADENOPATHY |
9 |
0.0003 |
| 722 |
ARRHYTHMIA |
12 |
0.0003 |
| 723 |
MENTAL DISORDER |
11 |
0.0003 |
| 724 |
DISEASE RECURRENCE |
12 |
0.0003 |
| 725 |
MYOCLONUS |
3 |
0.0003 |
| 726 |
ACCIDENT |
3 |
0.0003 |
| 727 |
WOUND |
7 |
0.0003 |
| 728 |
NAUSEA |
198 |
0.0002 |
| 729 |
ECZEMA |
13 |
0.0002 |
| 730 |
PRODUCT PHYSICAL ISSUE |
5 |
0.0002 |
| 731 |
NOCTURIA |
3 |
0.0002 |
| 732 |
MUSCLE TIGHTNESS |
4 |
0.0002 |
| 733 |
PRESYNCOPE |
6 |
0.0002 |
| 734 |
BACK DISORDER |
4 |
0.0002 |
| 735 |
BRADYCARDIA |
13 |
0.0002 |
| 736 |
PRODUCT DOSE OMISSION |
16 |
0.0002 |
| 737 |
BODY TEMPERATURE INCREASED |
5 |
0.0002 |
| 738 |
ADVERSE DRUG REACTION |
22 |
0.0002 |
| 739 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
0.0002 |
| 740 |
CARDIOMEGALY |
3 |
0.0002 |
| 741 |
INJECTION SITE MASS |
9 |
0.0002 |
| 742 |
LUNG NEOPLASM MALIGNANT |
10 |
0.0002 |
| 743 |
ABDOMINAL PAIN |
56 |
0.0002 |
| 744 |
ROAD TRAFFIC ACCIDENT |
10 |
0.0002 |
| 745 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0002 |
| 746 |
BRAIN OEDEMA |
3 |
0.0002 |
| 747 |
TRANSIENT ISCHAEMIC ATTACK |
8 |
0.0002 |
| 748 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
8 |
0.0002 |
| 749 |
ANAEMIA |
45 |
0.0002 |
| 750 |
MYALGIA |
40 |
0.0002 |
| 751 |
GAIT DISTURBANCE |
45 |
0.0002 |
| 752 |
RASH |
102 |
0.0002 |
| 753 |
ARTHROPATHY |
13 |
0.0002 |
| 754 |
LIVER FUNCTION TEST INCREASED |
5 |
0.0002 |
| 755 |
UNRESPONSIVE TO STIMULI |
6 |
0.0002 |
| 756 |
HAEMATOMA |
6 |
0.0002 |
| 757 |
TOXICITY TO VARIOUS AGENTS |
39 |
0.0002 |
| 758 |
DIPLOPIA |
6 |
0.0002 |
| 759 |
HAEMORRHAGE |
24 |
0.0002 |
| 760 |
MUSCLE SPASMS |
42 |
0.0002 |
| 761 |
RASH MACULAR |
8 |
0.0002 |
| 762 |
JOINT STIFFNESS |
6 |
0.0002 |
| 763 |
FEMUR FRACTURE |
7 |
0.0002 |
| 764 |
HEAD DISCOMFORT |
4 |
0.0002 |
| 765 |
GALLBLADDER DISORDER |
4 |
0.0002 |
| 766 |
SKIN BURNING SENSATION |
16 |
0.0002 |
| 767 |
RASH PAPULAR |
5 |
0.0002 |
| 768 |
FREQUENT BOWEL MOVEMENTS |
6 |
0.0002 |
| 769 |
PSORIATIC ARTHROPATHY |
9 |
0.0002 |
| 770 |
PULMONARY EMBOLISM |
21 |
0.0002 |
| 771 |
OSTEOMYELITIS |
4 |
0.0002 |
| 772 |
PALLOR |
6 |
0.0002 |
| 773 |
HEPATIC ENZYME INCREASED |
15 |
0.0002 |
| 774 |
TREATMENT NONCOMPLIANCE |
12 |
0.0002 |
| 775 |
CENTRAL NERVOUS SYSTEM LESION |
3 |
0.0002 |
| 776 |
RESPIRATORY ARREST |
6 |
0.0002 |
| 777 |
TINNITUS |
10 |
0.0002 |
| 778 |
DEEP VEIN THROMBOSIS |
14 |
0.0002 |
| 779 |
HUNGER |
3 |
0.0002 |
| 780 |
THROMBOCYTOPENIA |
24 |
0.0002 |
| 781 |
BLOOD CREATININE INCREASED |
14 |
0.0002 |
| 782 |
THERAPY CESSATION |
11 |
0.0002 |
| 783 |
BURNING SENSATION |
15 |
0.0002 |
| 784 |
BLOOD TEST ABNORMAL |
3 |
0.0002 |
| 785 |
INFLAMMATION |
11 |
0.0002 |
| 786 |
SKIN REACTION |
3 |
0.0002 |
| 787 |
WHITE BLOOD CELL COUNT DECREASED |
23 |
0.0002 |
| 788 |
ALANINE AMINOTRANSFERASE INCREASED |
13 |
0.0002 |
| 789 |
FEBRILE NEUTROPENIA |
14 |
0.0002 |
| 790 |
BLOOD PRESSURE DECREASED |
14 |
0.0002 |
| 791 |
NERVOUSNESS |
11 |
0.0002 |
| 792 |
MUSCULOSKELETAL DISORDER |
4 |
0.0002 |
| 793 |
DEATH |
181 |
0.0002 |
| 794 |
CARDIOGENIC SHOCK |
3 |
0.0002 |
| 795 |
ACCIDENTAL UNDERDOSE |
3 |
0.0002 |
| 796 |
PANCREATIC CARCINOMA |
6 |
0.0002 |
| 797 |
GLAUCOMA |
4 |
0.0002 |
| 798 |
ERUCTATION |
4 |
0.0002 |
| 799 |
PLASMA CELL MYELOMA |
8 |
0.0002 |
| 800 |
SKIN FISSURES |
4 |
0.0002 |
| 801 |
DRUG DOSE OMISSION BY DEVICE |
16 |
0.0002 |
| 802 |
DISTURBANCE IN ATTENTION |
11 |
0.0002 |
| 803 |
INJECTION SITE REACTION |
14 |
0.0002 |
| 804 |
LIVER DISORDER |
9 |
0.0002 |
| 805 |
DELIRIUM |
7 |
0.0002 |
| 806 |
DRUG INEFFECTIVE |
265 |
0.0002 |
| 807 |
HAEMORRHAGE INTRACRANIAL |
3 |
0.0002 |
| 808 |
SOMNOLENCE |
40 |
0.0002 |
| 809 |
ACNE |
15 |
0.0002 |
| 810 |
PRODUCT COMPLAINT |
5 |
0.0002 |
| 811 |
FEEDING DISORDER |
4 |
0.0002 |
| 812 |
DEVICE FAILURE |
3 |
0.0002 |
| 813 |
VERTIGO |
12 |
0.0002 |
| 814 |
PAIN IN EXTREMITY |
58 |
0.0002 |
| 815 |
HIP ARTHROPLASTY |
3 |
0.0002 |
| 816 |
INJECTION SITE SWELLING |
15 |
0.0002 |
| 817 |
HYPOPHAGIA |
5 |
0.0002 |
| 818 |
PHARYNGEAL OEDEMA |
3 |
0.0002 |
| 819 |
INJECTION SITE WARMTH |
4 |
0.0002 |
| 820 |
PRODUCT STORAGE ERROR |
17 |
0.0002 |
| 821 |
INTENTIONAL PRODUCT USE ISSUE |
17 |
0.0002 |
| 822 |
TENDONITIS |
3 |
0.0002 |
| 823 |
EJECTION FRACTION DECREASED |
3 |
0.0002 |
| 824 |
INJECTION SITE PAIN |
59 |
0.0002 |
| 825 |
PRODUCT QUALITY ISSUE |
26 |
0.0002 |
| 826 |
RESTLESSNESS |
7 |
0.0002 |
| 827 |
MUCOSAL INFLAMMATION |
5 |
0.0002 |
| 828 |
DERMATITIS |
4 |
0.0002 |
| 829 |
SPEECH DISORDER |
10 |
0.0002 |
| 830 |
RECTAL HAEMORRHAGE |
8 |
0.0002 |
| 831 |
IRRITABILITY |
11 |
0.0002 |
| 832 |
THERAPEUTIC RESPONSE DECREASED |
11 |
0.0002 |
| 833 |
DRUG LEVEL INCREASED |
3 |
0.0002 |
| 834 |
PSYCHOMOTOR HYPERACTIVITY |
3 |
0.0002 |
| 835 |
HYPOAESTHESIA |
27 |
0.0002 |
| 836 |
COAGULOPATHY |
3 |
0.0002 |
| 837 |
NEOPLASM MALIGNANT |
12 |
0.0002 |
| 838 |
CONFUSIONAL STATE |
29 |
0.0002 |
| 839 |
BLOOD UREA INCREASED |
3 |
0.0002 |
| 840 |
DEVICE ISSUE |
16 |
0.0002 |
| 841 |
PARAESTHESIA |
28 |
0.0002 |
| 842 |
HYPONATRAEMIA |
10 |
0.0002 |
| 843 |
AGITATION |
13 |
0.0002 |
| 844 |
PRODUCT AVAILABILITY ISSUE |
4 |
0.0002 |
| 845 |
INJECTION SITE BRUISING |
14 |
0.0002 |
| 846 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
3 |
0.0002 |
| 847 |
PARANOIA |
3 |
0.0002 |
| 848 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
5 |
0.0002 |
| 849 |
MULTI-ORGAN FAILURE |
3 |
0.0002 |
| 850 |
SYRINGE ISSUE |
3 |
0.0002 |
| 851 |
PANCREATITIS |
9 |
0.0002 |
| 852 |
LYMPHOCYTE COUNT DECREASED |
3 |
0.0002 |
| 853 |
LABORATORY TEST ABNORMAL |
5 |
0.0002 |
| 854 |
DRUG ABUSE |
14 |
0.0002 |
| 855 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 856 |
RENAL IMPAIRMENT |
14 |
0.0002 |
| 857 |
BLOOD GLUCOSE DECREASED |
8 |
0.0002 |
| 858 |
MENTAL IMPAIRMENT |
4 |
0.0002 |
| 859 |
STOMATITIS |
10 |
0.0002 |
| 860 |
BONE DISORDER |
3 |
0.0002 |
| 861 |
FIBROMYALGIA |
4 |
0.0002 |
| 862 |
UNDERDOSE |
12 |
0.0002 |
| 863 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
3 |
0.0002 |
| 864 |
EPILEPSY |
5 |
0.0002 |
| 865 |
INJECTION SITE URTICARIA |
4 |
0.0002 |
| 866 |
DYSURIA |
6 |
0.0002 |
| 867 |
ENCEPHALOPATHY |
4 |
0.0002 |
| 868 |
INCORRECT DOSE ADMINISTERED |
37 |
0.0002 |
| 869 |
LIMB DISCOMFORT |
5 |
0.0002 |
| 870 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
4 |
0.0002 |
| 871 |
THINKING ABNORMAL |
3 |
0.0002 |
| 872 |
DISEASE PROGRESSION |
19 |
0.0002 |
| 873 |
BONE DENSITY DECREASED |
5 |
0.0002 |
| 874 |
PHOTOPHOBIA |
3 |
0.0002 |
| 875 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
4 |
0.0002 |
| 876 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 877 |
ALOPECIA |
31 |
0.0002 |
| 878 |
PROTEINURIA |
3 |
0.0002 |
| 879 |
JOINT SWELLING |
19 |
0.0002 |
| 880 |
COLITIS ULCERATIVE |
7 |
0.0002 |
| 881 |
DRUG RESISTANCE |
4 |
0.0002 |
| 882 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
4 |
0.0002 |
| 883 |
LACTIC ACIDOSIS |
5 |
0.0002 |
| 884 |
HAEMORRHOIDS |
3 |
0.0002 |
| 885 |
BONE PAIN |
9 |
0.0002 |
| 886 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
31 |
0.0002 |
| 887 |
OVERDOSE |
33 |
0.0002 |
| 888 |
SUICIDAL IDEATION |
14 |
0.0002 |
| 889 |
IMPAIRED HEALING |
5 |
0.0002 |
| 890 |
ABNORMAL BEHAVIOUR |
6 |
0.0002 |
| 891 |
BLOOD CHOLESTEROL INCREASED |
7 |
0.0002 |
| 892 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
7 |
0.0001 |
| 893 |
URINARY RETENTION |
5 |
0.0001 |
| 894 |
INJECTION SITE PRURITUS |
10 |
0.0001 |
| 895 |
FULL BLOOD COUNT DECREASED |
3 |
0.0001 |
| 896 |
BLOOD GLUCOSE INCREASED |
28 |
0.0001 |
| 897 |
INTENTIONAL PRODUCT MISUSE |
13 |
0.0001 |
| 898 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 899 |
LOSS OF CONSCIOUSNESS |
19 |
0.0001 |
| 900 |
CEREBROVASCULAR ACCIDENT |
25 |
0.0001 |
| 901 |
HYPERHIDROSIS |
19 |
0.0001 |
| 902 |
BLINDNESS |
6 |
0.0001 |
| 903 |
SKIN LESION |
4 |
0.0001 |
| 904 |
ACCIDENTAL EXPOSURE TO PRODUCT |
15 |
0.0001 |
| 905 |
HAEMATOCHEZIA |
8 |
0.0001 |
| 906 |
MENTAL STATUS CHANGES |
4 |
0.0001 |
| 907 |
DEVICE USE ERROR |
5 |
0.0001 |
| 908 |
HALLUCINATION, VISUAL |
3 |
0.0001 |
| 909 |
ADVERSE EVENT |
13 |
0.0001 |
| 910 |
PLATELET COUNT DECREASED |
15 |
0.0001 |
| 911 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 912 |
NO ADVERSE EVENT |
25 |
0.0001 |
| 913 |
FLUSHING |
14 |
0.0001 |
| 914 |
ACUTE MYOCARDIAL INFARCTION |
4 |
0.0001 |
| 915 |
URINARY INCONTINENCE |
4 |
0.0001 |
| 916 |
DRUG INTOLERANCE |
13 |
0.0001 |
| 917 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
6 |
0.0001 |
| 918 |
DRUG DOSE OMISSION |
22 |
0.0001 |
| 919 |
DYSARTHRIA |
5 |
0.0001 |
| 920 |
HALLUCINATION |
10 |
0.0001 |
| 921 |
LOWER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 922 |
DIABETES MELLITUS |
10 |
0.0001 |
| 923 |
SKIN IRRITATION |
6 |
0.0001 |
| 924 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0001 |
| 925 |
COMA |
6 |
0.0001 |
| 926 |
MOOD SWINGS |
4 |
0.0001 |
| 927 |
MOVEMENT DISORDER |
4 |
0.0001 |
| 928 |
NIGHT SWEATS |
4 |
0.0001 |
| 929 |
INTERSTITIAL LUNG DISEASE |
6 |
0.0001 |
| 930 |
DEVICE BREAKAGE |
5 |
0.0001 |
| 931 |
LIVER INJURY |
3 |
0.0001 |
| 932 |
INFLUENZA LIKE ILLNESS |
10 |
0.0001 |
| 933 |
HOT FLUSH |
9 |
0.0001 |
| 934 |
ANGER |
4 |
0.0001 |
| 935 |
NIGHTMARE |
4 |
0.0001 |
| 936 |
DEVICE LEAKAGE |
5 |
0.0001 |
| 937 |
ILL-DEFINED DISORDER |
7 |
0.0001 |
| 938 |
MUSCULOSKELETAL STIFFNESS |
10 |
0.0001 |
| 939 |
GASTRITIS |
3 |
0.0001 |
| 940 |
INJECTION SITE ERYTHEMA |
14 |
0.0001 |
| 941 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
4 |
0.0001 |
| 942 |
GENERAL PHYSICAL HEALTH DETERIORATION |
13 |
0.0001 |
| 943 |
BREAST CANCER FEMALE |
3 |
0.0001 |
| 944 |
FEAR |
3 |
0.0001 |
| 945 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 946 |
CRYING |
4 |
0.0001 |
| 947 |
C-REACTIVE PROTEIN INCREASED |
4 |
0.0001 |
| 948 |
ACCIDENTAL OVERDOSE |
4 |
0.0001 |
| 949 |
CARDIAC ARREST |
9 |
0.0001 |
| 950 |
HEPATIC FUNCTION ABNORMAL |
4 |
0.0001 |
| 951 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 952 |
PSYCHOTIC DISORDER |
3 |
0.0001 |
| 953 |
DISORIENTATION |
4 |
0.0001 |
| 954 |
APHASIA |
3 |
0.0001 |
| 955 |
EMOTIONAL DISTRESS |
12 |
0.0001 |
| 956 |
DYSKINESIA |
4 |
0.0001 |
| 957 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 958 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 959 |
MALIGNANT NEOPLASM PROGRESSION |
10 |
0.0001 |
| 960 |
MYOCARDIAL INFARCTION |
17 |
0.0001 |
| 961 |
EMOTIONAL DISORDER |
3 |
0.0001 |
| 962 |
RHEUMATOID ARTHRITIS |
11 |
0.0001 |
| 963 |
NERVOUS SYSTEM DISORDER |
3 |
0.0001 |
| 964 |
DEPRESSED MOOD |
5 |
0.0001 |
| 965 |
HYPOACUSIS |
4 |
0.0001 |
| 966 |
OSTEONECROSIS |
3 |
0.0001 |
| 967 |
VISUAL ACUITY REDUCED |
3 |
0.0001 |
| 968 |
MEDICATION ERROR |
5 |
0.0001 |
| 969 |
NEUTROPENIA |
12 |
0.0001 |
| 970 |
GASTRIC DISORDER |
3 |
0.0001 |
| 971 |
NEOPLASM PROGRESSION |
3 |
0.0001 |
| 972 |
INJURY |
6 |
0.0001 |
| 973 |
PSORIASIS |
11 |
0.0001 |
| 974 |
PRODUCT ADHESION ISSUE |
3 |
0.0001 |
| 975 |
SKIN EXFOLIATION |
7 |
0.0001 |
| 976 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 977 |
AGGRESSION |
4 |
0.0001 |
| 978 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 979 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 980 |
PANCYTOPENIA |
4 |
0.0001 |
| 981 |
CONVULSION |
4 |
0.0001 |
| 982 |
BLADDER CANCER |
4 |
0.0001 |
| 983 |
INJECTION SITE HAEMORRHAGE |
5 |
0.0001 |
| 984 |
LEUKOPENIA |
3 |
0.0001 |
| 985 |
MUSCULOSKELETAL PAIN |
3 |
0.0001 |
| 986 |
BREAST CANCER |
5 |
0.0001 |
| 987 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 988 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 989 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
3 |
0.0000 |
| 990 |
TREATMENT FAILURE |
3 |
0.0000 |
| 991 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |